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lateral nephrectomy.5 To show this decisively, future studies
should quantitate the amount of thyroid-binding globulin in pleural
fluid.
Conclusion
When chest tube drainage leads to loss of Ig and ATIII, it is
important to document that thyroid function is normal. Although
the mechanism by which hypothyroidism occurs is not conclu-
sively proven, thyroid hormone replacement may be necessary in
instances in which prolonged chest tube drainage occurs.
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Stage III empyema caused by Actinomyces meyeri:
A plea for decortication
Ce´dric Vallet,a Edgardo Pezzetta,a Genevie`ve Nicolet-Chatelin,b Zihad El Lamaa,b
Olivier Martinet,a and Hans-Beat Ris,a Lausanne, Switzerland
Actinomycosis is a rare infectious disease caused byActinomyces species, a genus of anaerobic gram-pos-itive bacillus. Actinomyces organisms are saprophytesof the human digestive tract and are very sensitive to
penicillin. Thoracic actinomycosis represents 15% to 20% of cas-
es1-4 with pleural effusion in only 20% of intrathoracic affec-
tion.1,4,5 The usual clinical picture is that of a pleural effusion or
pleural empyema together with a parenchymatous infection. We
report a case of pleural effusion caused by Actinomyces meyeri
without pulmonary involvement that failed to respond to chest tube
drainage and antibiotherapy.
Clinical Summary
A 64-year-old woman was admitted with a history of fever and a
dry cough associated with asthenia, weight loss, and exertional
dyspnea. There was no previous medical history except for smok-
ing and alcohol abuse. Laboratory studies showed a hemoglobin
value of 9.9 g/100 mL, a hematocrit value of 25%, a leukocyte
count of 13,200/mm3, and a sedimentation rate of greater than 120
mm/h. Hemocultures were sterile, and the result of an HIV test was
negative. A chest radiograph
showed a massive left pleural
effusion (Figure 1). Chest
tube drainage was performed,
and this revealed a purulent
effusion. A meyeri was iden-
tified after culture of the pleu-
ral effusion. Despite treat-
ment with intravenous penicillin (20 Mio IU/d), a loculated pleural
effusion developed. Chest computed tomography (CT) demon-
strated thickening and enhancement of the parietal pleura and
confirmed loculation of pleural effusion and left lower lobe atel-
ectasis (Figure 2). Bronchial carcinoma was excluded by means of
bronchoscopy and transbronchial biopsy of the left lower lobe.
Pulmonary function testing revealed moderated obstruction and an
important restriction, with a forced expiratory volume in 1 second
of 1.04 L (47% of predicted value), a forced vital capacity of 1.72
L (66% of predicted value), and a total lung capacity of 3.58 L
(72% of predicted value). The patient remained febrile without
clinical improvement and complained of pain at the site of previ-
ous drainage. A stage III empyema was diagnosed, and an oper-
ation was performed.
At thoracotomy, we found a pleurosubcutaneous fistula at the
site of thoracic drainage mimicking an empyema necessitatis. The
parietal and visceral pleura were thickened and adherent to adja-
cent structures, as usually seen in advanced mesothelioma. Decor-
tication was performed with resection of the sinus tract, including
the sixth rib and its interspace. Microbiologic examination of the
pleura was performed, and A meyeri was found in the pleural
loculations filled with putrid liquid. The patient presented no
postoperative complication and was discharged after 16 days. An
oral penicillin regimen was prescribed for 6 months. Clinical and
radiologic evolutions were favorable, with minimal pleural sequel-
lae on chest radiography. Functional evaluation at 6 months after
the operation revealed a forced expiratory volume in 1 second of
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1.49 L (68% of predicted value) and a forced vital capacity of 2.52
L (96% of predicted value). The patient gained weight, and tho-
racic pain disappeared. Fiberoptic bronchoscopy 7 months after the
operation revealed a benign fibroepithelial polyp at the origin of
the lower lobe bronchus that was resected with biopsy forceps.
Bacteriologic cultures of bronchial aspiration remained sterile.
Discussion
The genus Actinomyces consists of gram-positive, non–acid-fast,
nonmotile organisms that never produce spores and usually require
an anaerobic environment for growth. Actinomyces organisms are
considered bacteria because of their cell-wall component and sus-
ceptibility to antibacterial drugs, such as penicillin.6 Actinomyco-
sis is a chronic, suppurative granulomatous infection. It typically
involves cervicofacial and abdominopelvic organs. Thoracic in-
volvement is less frequent.
Actinomyces species are commensals of the human oropharynx,
gastrointestinal tract, and female genitalia and are often routinely
cultured from these mucosa-lined orifices. Fourteen species have
been characterized to date.7 Six of these are thought to be patho-
genic in human subjects, including Actinomyces israelii, Actino-
myces neslundi, Actinomyces odontolyticus, Actinomyces viscosus,
A meyeri, and Actinomyces gerencseriae, and A israelli is the
organism most commonly incriminated in human disease. In con-
trast to other species, A meyeri might have a greater tendency of
affecting the lung and hematogenous dissemination. A meyeri is an
obligatory anaerobe organism that can be distinguished from other
Actinomyces species on the basis of colony morphologic aspects,
biochemical tests, acid production, end products from sugars, and
cell-wall peptidoglycan analysis.6 These microorganisms might
become pathogenic in debilitated patients who abuse alcohol and
have bad oral hygiene. Infection is prevalent in men aged 30 to 50
years.2,3,8
A crucial step in the development of clinical manifestation of
the disease is the disruption of the mucosal barrier, allowing the
organisms to invade. Pulmonary infection usually occurs after
bronchial aspiration of oropharyngeal or gastrointestinal contents
and rarely after an esophageal injury or by means of hematogenous
spread. Pleural actinomycosis starts as a bronchopulmonary dis-
ease and involves the pleura through lymphatic spread.9 Aspiration
of saliva or other material containing Actinomyces species might
then cause atelectasis and pneumonitis. The initial acute inflam-
mation is followed by the characteristic chronic and indolent phase
of the disease that generates abscesses, necrosis, and fibrosis of
lung parenchyma, which commonly cavitates. It progresses slowly
without respecting anatomic boundaries, such as interlobar fissures
or the chest wall. If not recognized, the parenchymal disease
invades the pleura, the chest wall, soft tissues, and bony structures.
Sinus tract formation and empyema necessitatis might arise, caus-
ing purulent discharge with yellowish sulfur granules.10 In our
patient the sinus tract followed the chest tube into the subcutane-
ous tissue at the time of the operation, with imminent fistulization
of the skin.
Clinical features are nonspecific and similar to those of other
chronic suppurative chest diseases. Physical signs are equally
nonspecific except in advanced and untreated disease, during
which fistulization might be seen.
Imaging is useful in evaluating the extent and chronicity of
disease. Definitive diagnosis is confirmed by means of histologic
or microbiologic examination confirmation. Plain chest radiograph
findings in actinomycosis are nonspecific. CT is more helpful in
providing information on parenchymal involvement and extension
into the adjacent chest wall. Pleural effusion with or without
Figure 2. Chest CT scan showing loculated effusion, pleural
enhancement, and atelectasis of the left lower lobe without signs
of parenchymal actinomycosis.
Figure 1. Chest radiograph showing pleural effusion related to A
meyeri.
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pleural thickening might also be diagnosed on the basis of CT
scans.
Compared with pulmonary actinomycosis, the bacteriologic
diagnosis is easily obtained by means of thoracocentesis in case of
pleural involvement. However, diagnosis might be obscured by
previous antibiotic therapy and a lack of anaerobic conditions for
culture. At direct microbiologic examination, actinomycosis has to
be suspected if gram-positive filamentous germs are discovered.
An anaerobic enriched environment is needed for appropriate
culture.
Penicillin G still remains the drug of choice, and the mainstay
of treatment is the administration of high-dose intravenous peni-
cillin. Eighteen to 24 millions units of penicillin per day are given
for 2 to 6 weeks, followed by oral penicillin V administration for
another 6 to 12 months. The evolution should be monitored by use
of plain radiographs or CT.
In stage I empyema, indication for surgical intervention is
uncommon, but the efficacy of antibiotic therapy depends on the
onset of diagnosis. If the treatment is delayed, stage II and III
empyemas can develop, and decortication is required. Chest-wall
fistulization has to be resected during the intervention. A VATS
approach is usually unrewarding because of the chronicity of
empyema at the time of the operation. After the operation, peni-
cillin administration is recommended.
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Thoracic endometriosis: A case report and literature review
Tomasz M. Ziedalski, MD,a,b Viji Sankaranarayanan, MD,a,b and Rajinder K. Chitkara, MD,a,b Palo Alto, Calif
Thoracic endometriosis is a rare disorder characterizedby the presence of functioning endometrial tissue withinthe pleura, the lung parenchyma, or the airways. In thisreport we describe a case of catamenial hemothorax and
review the various presentations, pathogenesis, diagnosis, and
therapies of thoracic endometriosis.
Clinical Summary
A 28-year-old woman was seen for cough, right-sided pleuritic
chest pain, and dyspnea. During the previous 3 years she had had
multiple hospitalizations for right-sided pneumothorax, hemo-
pneumothorax, and hemothorax. She had negative results of a
workup for pulmonary embolism and of a pleural biopsy. The
symptoms occurred within 24 to 48 hours after the onset of
menses. Danazol therapy was unsuccessful and she refused hys-
terectomy with oophorectomy. Examination revealed a pale,
mildly dyspneic woman with decreased breath sounds at the right
base of the lungs. Chest radiography demonstrated a right-sided
air-fluid level. Thoracentesis drained hemorrhagic fluid. Culture
results were negative, and cytologic examination demonstrated
endometrial epithelial cells with no evidence of malignancy. The
postthoracentesis chest radiograph showed a small rounded pleural
density and gas-liquid level on the right side. The patient subse-
quently underwent pleurectomy, with removal of the pleural im-
plant (Figures 1 and 2) and talc pleurodesis. One year later, she
was free of symptoms.
Discussion
Thoracic endometriosis is a rare disorder with varying clinical
presentations. The largest series reviewed 112 cases of thoracic
pathology associated with menstruation presenting as hemoptysis,
hemothorax, pneumothorax, or pulmonary nodules.1 The term
thoracic endometriosis syndrome (TES) was proposed. The mean
age at diagnosis was 35 years, with a range from 19 to 54 years.
Pneumothorax occurred in 73% of the cases, hemothorax in 14%,
hemoptysis in 7%, and nodules in 6%. Patients had chest pain in
90% of the cases and dyspnea in 31%. In 90% of patients, the
symptoms occurred within 2 days after the onset of menstruation.
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